OS THERAPIES INCORPORATED Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Exercise Price
OS THERAPIES INCORPORATED (OSTX) had Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Exercise Price of $1.12 per share as of 2025-06-30, per its 10-Q filed 2025-08-18.
Financial Statements › Notes › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions and Methodology
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice · last filed 2026-08-14
- 2025-06-30: Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Exercise Price $1.12.
- 2025-04-09: Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Exercise Price $1.12.
- 2025-03-31: Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Exercise Price $1.12.
- 2025-01-14: Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Exercise Price $4.40.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Exercise Price |
|---|---|
| 2025-06-30 | $1.12 10-Q · filed 2025-08-18 |
| 2025-04-09 | $1.12 10-Q · filed 2025-11-14 |
| 2025-03-31 | $1.12 10-Q · filed 2025-05-15 |
| 2025-01-14 | $4.40 10-Q · filed 2026-08-14 |
| 2024-12-31 | $4.40 10-Q · filed 2026-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |
| iBio, Inc. (IBIO) | United States | $0.077B | -2.94 |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |